SILO PHARMA, INC. (SILO) Operating cash flow 2017–2025
SILO PHARMA, INC. (SILO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2025 · since FY2017: -$284,618 → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | -21.6% |
| FY2024 | -$3.8M | -18.9% |
| FY2023 | -$3.2M | +7.8% |
| FY2022 | -$3.5M | -53.5% |
| FY2021 | -$2.3M | -96.9% |
| FY2020 | -$1.2M | -45.7% |
| FY2019 | -$794,324 | -391.3% |
| FY2018 | $272,637 | +195.8% |
| FY2017 | -$284,618 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SILO financial trends
SILO RevenueSILO Net incomeSILO Net marginSILO Gross profitSILO Gross marginSILO Operating incomeSILO Operating marginSILO Free cash flowSILO Capital expendituresSILO Return on equitySILO Stock buybacksSILO Dividends paidSILO Total assetsSILO Total liabilitiesSILO Shareholders’ equitySILO overview →